ArticleScientific reports2024

Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel.

Taro Shibuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.